HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use
Beta-carboline hydroxamic acid compounds represented by formula (I) are described. The beta-carboline hydroxamic acid compounds and compositions containing those compounds may be used to inhibit or modulate the activity of HIV integrase enzyme and to treat HIV integrase-mediated diseases and conditions.
Agouron Pharmaceuticals, Inc.
A A C
A61P A61P C07D
inventional inventional inventional
Junhu Michael Bruno Atsuo Hai Xinqiang
Zhang Plewe Kuki Wang Li